Organization
Lucence Diagnostics Pte. Ltd.
3 abstracts
Abstract
Association between CH mutation in TET2 and solid cancer in elderly Asian women.Org: Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Lucence Diagnostics Pte. Ltd., Department of Anatomical Pathology, Division of Pathology, Singapore General Hospital, Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore,
Abstract
Liquid biopsy in combination with PET/CT versus PET/CT alone in diagnosis of lung cancer in small nodules.Org: VA Palo Alto Health Care System, Lucence Health Inc, Lucence Diagnostics Pte. Ltd., Lucence Diagnostics Pte Ltd, Palo Alto Veterans Institute for Research,
Abstract
Longitudinal tracking of ALK-positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial.Org: University of Texas MD Anderson Cancer Center, MD Anderson Cancer Center, Lucence Health, Inc., Lucence Health Inc, Lucence Diagnostics Pte. Ltd.,